Sagimet Biosciences

SGMTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$559.471 M

$9.06 +3.66%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$51.0M

Loss-making

Shares outstanding

32,559,704

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#200ArvinasARVN$572.1M
#201Contineum TherapeuticsCTNM$565.8M
#202Sagimet BiosciencesSGMT$559.5M
#203Silence TherapeuticsSLN$559.3M
#204Shattuck LabsSTTK$557.5M

Where these numbers come from

Share counts and financials for Sagimet Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.